跳至主要内容
临床试验/EUCTR2005-001213-18-IT
EUCTR2005-001213-18-IT进行中(未招募)不适用

etrozole adjuvant therapy after tamoxifen. Study of gene CYP19 correlation with letrozole efficacy in postmenopausal early breast cancer patients

CONSORZIO ONCOTECH0 个研究点开始时间: 2005年9月2日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 未提供

研究者

相似试验

进行中(未招募)
不适用
etrozole adjuvant therapy duration (LEAD)study: standard versus long treatment. A phase III study in postmenopausal women with early breast cancer
EUCTR2005-001212-44-ITCONSORZIO ONCOTECH
进行中(未招募)
1 期
Phase III trial on concurrent and adjuvant temozolomide chemotherapy in non-1p/19q deleted anaplastic glioma. The CATNON intergroup trial. - NDnewly diagnosed anaplastic oligodendroglioma, anaplastic oligoastrocytoma or anaplastic astrocytoma by local diagnosisMedDRA version: 9.1 Level: LLT Classification code 10018338 Term: Glioma
EUCTR2006-001533-17-ITE.O.R.T.C. - EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER748
已完成
3 期
A randomised phase III Trial on concurrent and adjuvant Temozolomide chemotherapy in non 1p/19q deleted anaplastic glioma to evaluate overall survival.Anaplastic GliomaNeurological - Other neurological disordersCancer - Other cancer types
ACTRN12609000485235niversity of Sydney751
进行中(未招募)
1 期
Phase III trial on Concurrent and Adjuvant Temozolomide chemotherapy in non-1p/19q deleted anaplastic glioma. The CATNON Intergroup trial.anaplastic gliomaMedDRA version: 20.0Level: PTClassification code 10018337Term: Glioblastoma multiformeSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2006-001533-17-NLEORTC European Organisation for research and treatment of cancer751
进行中(未招募)
1 期
Phase III trial on Concurrent and Adjuvant Temozolomide chemotherapy in non-1p/19q deleted anaplastic glioma. The CATNON Intergroup trial.anaplastic gliomaMedDRA version: 9.1 Level: LLT Classification code 10018337 Term: Glioblastoma multiforme
EUCTR2006-001533-17-ESEORTC European Organisation for research and treatment of cancer748